Updated:
Invitae Corporation
Invitae and Labcorp together offer advanced genetic testing services that can be integrated into medical practices. Improving care with DNA-based insights.
Invitae Corporation
Invitae and Labcorp together offer advanced genetic testing services that can be integrated into medical practices. Improving care with DNA-based insights.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Frequently asked questions
Who runs investment decisions at Invitae Corporation?
As Invitae has been acquired by Labcorp, investment decisions are now made by Labcorp's management. The specific individuals are not disclosed in Invitae's public materials.
How does Invitae source proprietary deal flow?
Invitae does not operate as an investment firm; it is a genetic testing company. Its deal flow pertains to clinical partnerships and laboratory services, not investment opportunities.
Does Invitae participate in fund commitments or only direct deals?
Invitae is not structured as an investment vehicle. It engages in direct business operations and partnerships related to genetic testing, not fund investments.
What investment stages does Invitae typically target?
Invitae does not target investment stages. Its activities are clinical and commercial, focused on genetic testing and laboratory services.
Is Invitae structured as a single family office or does it operate more like a venture firm?
Invitae was a publicly traded corporation and is now a subsidiary of Labcorp. It does not operate as a family office or venture firm.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: